WDNA
WisdomTree BioRevolution Fund
Price Chart
Latest Quote
$20.02
+0.19 (+0.95%)
Current Price
| Previous Close | $19.83 |
| Open | $20.12 |
| Day High | $20.02 |
| Day Low | $20.02 |
| Volume | 35 |
Fund Information
| Quarterly Dividend / Yield | N/A / 3.74% |
| Net Assets | $2.68M |
| Expense Ratio | 0.45% |
| Category | Health |
| Fund Family | WisdomTree |
| Net Asset Value | $19.85 |
| Premium/Discount | 0.85% |
| Quarterly Dividend Yield | 3.74% |
| P/E Ratio | 24.34 |
| Exchange | BTS |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $20.28 |
| SMA50 | $18.84 |
| SMA200 | $17.60 |
| RSI | 46.16 |
| ATR | 0.6246 |
| Rel Volume | 0.06 |
Performance History
| Week | -2.35% |
| Month | +9.11% |
| Quarter | +9.05% |
| 6 Months | +10.20% |
| YTD | +18.30% |
| Year | +48.57% |
| 3 Years | +17.29% |
| 5 Years | -19.14% |
| 10 Years | -14.61% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $20.02 | 100 |
| 2026-07-16 | $19.83 | 200 |
| 2026-07-15 | $20.25 | 200 |
| 2026-07-14 | $20.19 | 100 |
| 2026-07-13 | $20.27 | 300 |
| 2026-07-10 | $20.50 | 1,400 |
| 2026-07-09 | $21.20 | 2,400 |
| 2026-07-08 | $21.07 | 400 |
| 2026-07-07 | $21.40 | 2,200 |
| 2026-07-06 | $21.23 | 6,300 |
| 2026-07-02 | $21.14 | 4,100 |
| 2026-07-01 | $20.66 | 3,600 |
| 2026-06-30 | $20.59 | 2,300 |
| 2026-06-29 | $20.54 | 1,000 |
| 2026-06-26 | $20.27 | 1,600 |
| 2026-06-25 | $19.85 | 1,500 |
| 2026-06-24 | $19.59 | 200 |
| 2026-06-23 | $19.12 | 200 |
| 2026-06-22 | $19.03 | 2,700 |
| 2026-06-18 | $18.86 | 400 |
About WisdomTree BioRevolution Fund
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on WDNA.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.